Clinical trials
Lymphoma, Non-Hodgkin trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nordic Nanovector | 2 |
| Novartis Pharmaceuticals | 2 |
| Bayer | 1 |
| Biotec Pharmacon ASA | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Loxo Oncology, Inc. | 1 |
| Lymphoma Trials Office | 1 |
| Nordic Lymphoma Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 14 |
| Lymphoma, Follicular | 6 |
| Lymphoma, B-Cell | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Burkitt Lymphoma | 1 |
| Central Nervous System Neoplasms | 1 |
| Hematologic Diseases | 1 |
| Lymphoma | 1 |
| Lymphoma, Large-Cell, Immunoblastic | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.